{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T23:43:03Z","timestamp":1794613383321,"version":"4.9.1"},"reference-count":28,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Comput Assist Tomogr"],"published-print":{"date-parts":[[2018,5]]},"abstract":"<jats:sec>\n            <jats:title>Objective<\/jats:title>\n            <jats:p>The aim of the study was to assess the prognostic impact of volume-based metabolic <jats:sup>18<\/jats:sup>F-fluorodeoxyglucose\u2013positron emission tomography\/ computed tomography (<jats:sup>18<\/jats:sup>F-FDG\u2013PET\/CT) parameters in patients with stage IB\u2013IVA squamous cell cervical carcinoma (SCCC).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Materials and Methods<\/jats:title>\n            <jats:p>We reviewed the pretreatment <jats:sup>18<\/jats:sup>F-FDG\u2013PET\/CT records of 67 patients with stage IB\u2013IVA SCCC. The maximum standardized uptake value (SUVmax) of the primary tumor (PSUVmax), highest SUVmax of the whole malignant lesions (WSUVmax), metabolic tumor volume (MTV) of the primary tumor (PMTV), MTV of the whole malignant lesion (WMTV), total lesion glycolysis (TLG) of primary tumor (PTLG), and TLG of the whole malignant lesion (WTLG) were obtained. Univariate and multivariate analyses were performed to assess the predictive values of metabolic parameters.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Twenty-nine patients showed disease progression and 21 patients died during follow-up. In univariate analysis, positive lymph node, WSUVmax of greater than 11, WMTV of greater than 63 cm<jats:sup>3<\/jats:sup>, and WTLG of greater than 373 adversely affected the progression-free survival (<jats:italic toggle=\"yes\">P<\/jats:italic> = 0.004, 0.045, 0.023, and 0.005, respectively). A positive lymph node, WSUVmax of greater than 12, WMTV of greater than 68 cm<jats:sup>3<\/jats:sup>, and WTLG of greater than 373 significantly adversely affected overall survival (<jats:italic toggle=\"yes\">P<\/jats:italic> = 0.002, 0.032, 0.015, and 0.006, respectively). In multivariate analysis, independent prognostic factor for progression-free survival was WTLG (relative risk = 2.384, 95% confidence interval = 1.095\u20135.187, <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.029). Independent prognostic factors for overall survival was WTLG (relative risk = 2.763; 95% confidence interval = 1.107\u20136.896, <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.029).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Preliminary results indicated that pretreatment WTLG measured by F-FDG\u2013PET\/CT could independently predict survival in patients with locally advanced SCCC.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/rct.0000000000000708","type":"journal-article","created":{"date-parts":[[2018,1,25]],"date-time":"2018-01-25T13:45:11Z","timestamp":1516887911000},"page":"429-434","source":"Crossref","is-referenced-by-count":13,"title":["Prognostic Value of Volume-Based Metabolic Parameters Obtained by 18F-FDG\u2013PET\/CT in Patients With Locally Advanced Squamous Cell Cervical Carcinoma"],"prefix":"10.1097","volume":"42","author":[{"given":"Ying","family":"Liang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaomeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"bib1-20230927","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3322\/caac.20006","article-title":"Cancer statistics, 2009","volume":"59","year":"2009","journal-title":"CA Cancer J Clin"},{"key":"bib2-20230927","first-page":"1","article-title":"National cancer incidence and mortality in China, 2012","volume":"28","year":"2016","journal-title":"Chin J Cancer Res"},{"key":"bib3-20230927","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1102\/1470-7330.2008.0022","article-title":"The prognostic value of PET and PET\/CT in cervical cancer","volume":"8","year":"2008","journal-title":"Cancer Imaging"},{"key":"bib4-20230927","doi-asserted-by":"crossref","first-page":"2776","DOI":"10.1002\/1097-0142(19910601)67:11<2776::AID-CNCR2820671111>3.0.CO;2-L","article-title":"Carcinoma of the cervix treated with radiation therapy. I. A multi-variate analysis of prognostic variables in the Gynecologic Oncology Group","volume":"67","year":"1991","journal-title":"Cancer"},{"key":"bib5-20230927","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1016\/S0360-3016(02)04477-2","article-title":"Assessing tumor hypoxia in cervical cancer by positron emission tomography with 60Cu-ATSM: relationship to therapeutic response-a preliminary report","volume":"55","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"bib6-20230927","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ygyno.2009.06.022","article-title":"The prognostic significance of the SUVmax (maximum standardized uptake value for F-18 fluorodeoxyglucose) of the cervical tumor in PET imaging for early cervical cancer: preliminary results","volume":"115","year":"2009","journal-title":"Gynecol Oncol"},{"key":"bib7-20230927","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1002\/cncr.22974","article-title":"The standardized uptake value for F-18 fluorodeoxyglucose is a sensitive predictive biomarker for cervical cancer treatment response and survival","volume":"110","year":"2007","journal-title":"Cancer"},{"key":"bib8-20230927","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.ygyno.2007.03.018","article-title":"A prospective study of the accuracy of 18fluorodeoxyglucose positron emission tomography (18FDG PET) in identifying sites of metastasis prior to pelvic exenteration","volume":"106","year":"2007","journal-title":"Gynecol Oncol"},{"key":"bib9-20230927","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1097\/IGC.0b013e3182989483","article-title":"Prognostic value of pretreatment 18F-fluorodeoxyglucose uptake in patients with cervical cancer treated with definitive chemoradiotherapy","volume":"23","year":"2013","journal-title":"Int J Gynecol Cancer"},{"key":"bib10-20230927","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.ygyno.2010.04.020","article-title":"The predictive value of measurement of SUVmax and SCC-antigen in patients with pretreatment of primary squamous cell carcinoma of cervix","volume":"119","year":"2010","journal-title":"Gynecol Oncol"},{"key":"bib11-20230927","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1148\/radiol.12111148","article-title":"Prognostic value of whole-body total lesion glycolysis at pretreatment FDG PET\/CT in non-small cell lung cancer","volume":"264","year":"2012","journal-title":"Radiology"},{"key":"bib12-20230927","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.2967\/jnumed.111.101402","article-title":"18F-FDG PET\/CT metabolic tumor volume and total lesion glycolysis predict outcome in oropharyngeal squamous cell carcinoma","volume":"53","year":"2012","journal-title":"J Nucl Med"},{"key":"bib13-20230927","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1007\/s13139-010-0062-8","article-title":"The prognostic value of the metabolic tumor volume in FIGO stage IA to IIB cervical cancer for tumor recurrence: measured by F-18 FDG PET\/CT","volume":"45","year":"2011","journal-title":"Nucl Med Mol Imaging"},{"key":"bib14-20230927","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1002\/cam4.295","article-title":"Volumetric PET\/CT parameters predict local response of head and neck squamous cell carcinoma to chemoradiotherapy","volume":"3","year":"2014","journal-title":"Cancer Med"},{"key":"bib15-20230927","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1007\/s12149-013-0745-1","article-title":"Do clinical characteristics and metabolic markers detected on positron emission tomography\/computerized tomography associate with persistent disease in patients with in-operable cervical cancer?","volume":"27","year":"2013","journal-title":"Ann Nucl Med"},{"key":"bib16-20230927","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1002\/1097-0142(19951115)76:10+<1978::AID-CNCR2820761313>3.0.CO;2-K","article-title":"Prognostic factors of early stage cervical cancer treated by radical hysterectomy","volume":"76","year":"1995","journal-title":"Cancer"},{"key":"bib17-20230927","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/0090-8258(90)90374-T","article-title":"Adjuvant radiotherapy following radical hysterectomy for patients with stage IB and IIA cervical cancer","volume":"37","year":"1990","journal-title":"Gynecol Oncol"},{"key":"bib18-20230927","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.mibio.2003.12.004","article-title":"Positron emission tomography with 2-deoxy-2-[(18)F]fluoro-D-glucose for evaluating local and distant disease in patients with cervical cancer","volume":"6","year":"2004","journal-title":"Mol Imaging Biol"},{"key":"bib19-20230927","first-page":"192","article-title":"Improved prognostic value of 18F-FDG PET using a simple visual analysis of tumor characteristics in patients with cervical cancer","volume":"44","year":"2003","journal-title":"J Nucl Med"},{"key":"bib20-20230927","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s00432-011-1092-z","article-title":"The SUVmax (maximum standardized uptake value for F-18 fluorodeoxyglucose) and serum squamous cell carcinoma antigen (SCC-ag) function as prognostic biomarkers in patients with primary cervical cancer","volume":"138","year":"2012","journal-title":"J Cancer Res Clin Oncol"},{"key":"bib21-20230927","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1007\/s00259-010-1413-5","article-title":"Preoperative [18F]FDG PET\/CT maximum standardized uptake value predicts recurrence of uterine cervical cancer","volume":"37","year":"2010","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"bib22-20230927","doi-asserted-by":"crossref","first-page":"897","DOI":"10.2214\/AJR.14.12497","article-title":"Prognostic value of FDG PET metabolic tumor volume in human papillomavirus\u2013positive stage III and IV oropharyngeal squamous cell carcinoma","volume":"203","year":"2014","journal-title":"AJR Am J Roentgenol"},{"key":"bib23-20230927","doi-asserted-by":"crossref","first-page":"e15","DOI":"10.3802\/jgo.2016.27.e15","article-title":"Prognostic value of preoperative intratumoral FDG uptake heterogeneity in early stage uterine cervical cancer","volume":"27","year":"2016","journal-title":"J Gynecol Oncol"},{"key":"bib24-20230927","doi-asserted-by":"crossref","first-page":"e3017","DOI":"10.1097\/MD.0000000000003017","article-title":"Different prognostic implications of 18F-FDG PET between histological subtypes in patients with cervical cancer","volume":"95","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"bib25-20230927","doi-asserted-by":"crossref","first-page":"e0137743","DOI":"10.1371\/journal.pone.0137743","article-title":"Comparison of the prognostic value of F-18 PET metabolic parameters of primary tumors and regional lymph nodes in patients with locally advanced cervical cancer who are treated with concurrent chemoradiotherapy","volume":"10","year":"2015","journal-title":"PLoS One"},{"key":"bib26-20230927","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1097\/COC.0000000000000159","article-title":"Use of metabolic parameters as prognostic factors during concomitant chemoradiotherapy for locally advanced cervical cancer","volume":"40","year":"2017","journal-title":"Am J Clin Oncol"},{"key":"bib27-20230927","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s13014-016-0614-x","article-title":"[(18)F]FDG-PET\/CT metabolic parameters as useful prognostic factors in cervical cancer patients treated with chemo-radiotherapy","volume":"11","year":"2016","journal-title":"Radiat Oncol"},{"key":"bib28-20230927","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1007\/s00259-012-2127-7","article-title":"Use of pretreatment metabolic tumour volumes to predict the outcome of pharyngeal cancer treated by definitive radiotherapy","volume":"39","year":"2012","journal-title":"Eur J Nucl Med Mol Imaging"}],"container-title":["Journal of Computer Assisted Tomography"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00004728-201805000-00014","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,27]],"date-time":"2023-09-27T18:09:02Z","timestamp":1695838142000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00004728-201805000-00014"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":28,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1097\/rct.0000000000000708","relation":{},"ISSN":["1532-3145","0363-8715"],"issn-type":[{"value":"1532-3145","type":"electronic"},{"value":"0363-8715","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]}}}